Inotiv, Inc. Logo

Inotiv, Inc.

A CRO providing nonclinical drug development services and research models.

NOTV | US

Overview

Corporate Details

ISIN(s):
US09058M1036 (+1 more)
LEI:
Country:
United States of America
Address:
2701 KENT AVE, WEST LAFAYETTE

Description

Inotiv, Inc. is a contract research organization (CRO) providing a comprehensive range of nonclinical and analytical drug discovery and development services. Key service areas include general toxicology, pathology, histology, drug metabolism and pharmacokinetics (DMPK), and bioanalytical solutions. The company also offers specialized services such as digital pathology with AI-driven image analysis, monoclonal antibody production, and developmental and reproductive toxicology (DART) studies. In addition to its CRO services, Inotiv is a major provider of research models and related products. This includes a wide array of animal models, genetically engineered model services (GEMS), contract breeding, surgical services, and Teklad laboratory animal diets and bedding. Inotiv serves clients across the pharmaceutical, biotechnology, medical device, academic, and government sectors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-11 18:10
10-Q
English 2.1 MB
2023-08-10 18:11
8-K
English 150.0 KB
2023-05-15 18:24
10-Q
English 2.3 MB
2023-05-11 18:16
FORM 8-K
English 170.4 KB
2023-04-04 18:29
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.7 KB
2023-04-04 18:29
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.8 KB
2023-04-04 18:28
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.7 KB
2023-04-04 18:28
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.8 KB
2023-04-04 18:28
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.9 KB
2023-03-17 17:31
FORM 8-K
English 76.7 KB
2023-03-16 17:03
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.5 KB
2023-02-24 17:02
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.7 KB
2023-02-21 18:38
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 7.5 KB
2023-02-21 18:33
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.7 KB
2023-02-21 18:33
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 6.7 KB

Automate Your Workflow. Get a real-time feed of all Inotiv, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Inotiv, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Inotiv, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.